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Summary
Objectives: The incidence of leptospirosis, a worldwide zoonosis, has significantly
decreased in Western Europe during the last decades. Our aim was to analyse all
reliable data collected at the Institut Pasteur from 1920 to 2003 to evaluate more
precisely the evolution of the incidence of leptospirosis in France.
Methods: The passive surveillance system used as early as 1920 allows the evaluation
of leptospirosis incidence. Serological results inferred from the microagglutination
procedure were used to evaluate variation in the incidence of the disease and the
evolution of the Leptospira serogroups involved in the human disease.
Results: No significant variation either in the number of leptospirosis cases or in the
incidence of the disease was observed. However, the period of the 1970s was
characterized by a rather low incidence. The weather plays a major role by modifying
fresh water abundance, rodent populations and human behaviour. However the
weather’s influence is not the sole factor involved in the incidence rate. No cyclic
variation was evident.
Conclusion: Although France has the highest incidence of leptospirosis in Europe, the
analysis of serological data collected over 66 years has allowed us to conclude that in
France, the incidence is slowly decreasing.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.* Corresponding author. Tel.: +33 1 45688337;
fax: +33 1 40613001.
E-mail address: dpostic@pasteur.fr (D. Postic).
1201-9712/$32.00 # 2005 International Society for Infectious Diseas
doi:10.1016/j.ijid.2005.02.010Introduction
The face of leptospirosis is changing. The incidence
of the disease is decreasing in many developed
countries, probably correlated to individual and
collective measures of prevention (for instancees. Published by Elsevier Ltd. All rights reserved.
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standards of hygiene.1 This is the case mainly in
occupational situations where the associated risk is
decreasing, although in contrast, recreational lep-
tospirosis is more prominent due to water sport
activities.2
In developing and tropical countries, leptospiro-
sis is either emerging3 or is still highly prevalent.4
Urbanization in poor social conditions, such as in
Brazil, has led to severe outbreaks5 similar to epi-
demics.6 In many developing regions, demographic
pressure could lead to similar events.
In both developing and developed countries, lep-
tospirosis has also been associated with climatic
catastrophes, such as those in 1967 in Lisbon, the
capital of Portugal,7 in China in 1958,8 and more
recently in Nicaragua in 1995.9
Global climatic changes are expected to lead to
more frequent extreme events such as the recent
heat-wave observed in France in the summer of 2003
or the flooding observed in several European coun-
tries in 2002. This could lead to the re-emergence of
leptospirosis as severe outbreaks.
In Western European countries, the incidence of
leptospirosis has been decreasing. It has almost
disappeared in the Netherlands, Belgium, Germany
and Switzerland.1 In some other countries such as
the UK,10—12 Portugal13 and Spain,14 leptospirosis is
still notified in National Public Health reports. In
France however, when the raw data are analysed,
the number of cases is seen to increase from about
150 cases per year in the 1930s15 up to 300 cases in
the last 20 years (this study).Table 1 Chronology of antigen use in serological diagnosis of
procedure in the Institut Pasteur.
Serogroup, Serovar, strain
Icterohaemorrhagiae, Icterohaemorrhagiae, Verdun
Icterohaemorrhagiae, Copenhageni, Wijnberg
Grippotyphosa, Grippotyphosa, Moskva V
Pomona, Pomona, Pomona
Canicola, Canicola, Hond Utrecht
Australis, Australis, Ballico
Ballum, Castellonis, Castellon 3
Sejroe, Sejroe, M84
Bataviae, Bataviae, Swart
Tarassovi, Tarassovi, Perepelycin
Semaranga, Patoc, Patoc1a
Autumnalis, Autumnalis, Akiyami A
Cynopteri, Cynopteri, 3522 C
Sejroe, Hardjo, hardjobovis
Hebdomadis, Hebdomadis, Hebdomadis
Javanica, Javanica, Veldrat Batavia 46
Panama, Panama, CZ 214
Pyrogenes, Pyrogenes, Salinem
a Not considered in case definition.Many factors are involved in leptospirosis and
modify its incidence. Human behaviour could be
involved, for instance in recreational leptospirosis
as a result of increasing holidays from the late 1930s
and after the Second World War. Clearly demogra-
phy also plays a major role when considering abso-
lute numbers of cases as compared to incidence
rates. Global climate changes from the end of the
19th century could also have had a significant influ-
ence.
In France, a passive surveillance system was set
up soon after the discovery at the Institut Pasteur in
1917 of the ‘Agglutination Lysis Reaction’,16 later
called the Microscopic Agglutination Test (MAT).
Eighty-five years after its publication, this test
remains the gold standard for leptospirosis serolo-
gical diagnosis. It is nowadays characterized by the
use of a panel of antigens that detect most of the
locally prominent serovars. Taking advantage of the
long-standing use of sero-surveillance at a national
scale, our aim was to analyse all reliable data
collected at the Institut Pasteur from 1920 to
2003 to evaluate more precisely the evolution of
the incidence of leptospirosis in France.Materials and methods
All data analysed in this work were obtained from
the archives of the Institut Pasteur and from pre-
vious publications. Only serological results inferred
from the MAT procedure were used in order to
establish firstly the variation in the incidence ofleptospirosis by the Microscopic Agglutination Test (MAT)
Used from Up to
1920 1985
1985 now
1942 now
1945 now
1945 now
1952 now
1970 now
1970 now
1970 now
1970 now
1970 now
1985 now
1985 now
1985 now
1985 now
1985 now
1985 now
1985 now
164 G. Baranton, D. Posticthe disease and secondly the evolution of the Lep-
tospira serogroups involved in the human disease.
Annual reports are available only from 1970. How-
ever, data have been published from 1923 to 193215
and 1933 to 195217 in French journals. No data are
available from 1953 to 1970. Some data subsequent
to 1970 have previously been published18,19 other-
wise they were extracted from the unpublished
annual reports. Abstracts of the most recent reports
(from 1996) are available on the web.20
Demographic data were obtained from the Insti-
tut National de Statistiques21 and the Institut
National d’Etudes De´mographiques.22Results and discussion
Limits of interpretation
Although the passive surveillance system has been
continuous from 1920 until the present day, several
limits prevent the use of statistical validation of the
data or require caution when interpreting them:(1) CFigu
popuhanges in the panel of antigens used during
years studied (see Table 1). The strain Verdun,
belonging to the serovar Icterohaemorrhagiaere 1 Incidence of leptospirosis due to the serogroup Icteroh
lation.within the Icterohaemorrhagiae serogroup, was
the first strain to be isolated from a human by
Martin and Pettit in 1917.16 This strain has been
continuously used in the serological diagnosis
procedure (MAT) from 1917 up to 1985 when it
was replaced by a strain belonging to the ser-
ovar Copenhageni. The strain Verdun was the
only antigen used for serological diagnosis from
1917 to 1942 (Table 1). After the initial descrip-
tion of Leptospira icterohaemorrhagiae in
Japan in 1915,23 sera from human leptospirosis
cases not responding to the Icterohaemorrha-
giae antigen led to the description of new ser-
ovars successively named Hebdomadis (1918),
Autumnalis (1923), Pyrogenes (1923), Bataviae
(1926) and Grippotyphosa (1928). Progressively,
these antigenically unrelated strains have been
added to the Icterohaemorrhagiae antigen in
the MAT panel (Table 1). Between 1942 and
1952, strains representative of serogroups Cani-
cola, Grippotyphosa, Pomona and Australis were
also used in MAT in France. In 1970 and later,
their use was systematic. In 1985 new antigens
were added to the nine previously used serovars
in the MAT; these were Autumnalis, Cynopteri,
Hardjo, Hebdomadis, Javanica, Panama, and
Pyrogenes (Table 1).aemorrhagiae. Concomitant evolution of the French
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1920ack of complete coverage due to the non-
exclusivity of the Institut Pasteur in performing
the serological diagnosis of leptospirosis
throughout the studied period.(3) No clear and stable case definition over the 80
years. Currently, for epidemiological purposes,
a case in a low endemicity area such as con-
tinental France is defined by a threshold of 1/
100 against any of the pathogenic serovars used
in MAT. Usually the infecting serovar is identified
as that which gives the highest titre in a late
serum. Enzyme linked immunosorbent assay
(ELISA) is usually performed using the Patoc
serovar to detect IgM antibodies. This test,
similarly to the MATusing the sole Patoc serovar,
does not allow the identification of the ser-
ogroup responsible for the disease, therefore,
they are not considered in this work.Leptospirosis due to Icterohaemorrhagiae
serogroup
Data concerning the diagnosis recorded with either
the Icterohaemorrhagiae or Copenhageni antigens
are shown in Figure 1 in relation to demographicre 2 Annual number of leptospirosis cases due to both
to 2003.data. The increasing number of cases from 1920 to
193415 probably corresponds to the promotion and
increasing popularity of the serodiagnosis. Data
subsequent to 193517 indeed represent fluctuations
in the number of positive cases with the exception of
the period 1939—1944 when the Second World War
prevented normal access to diagnosis.
We found no drastic quantitative differences in
the absolute number of Icterohaemorrhagiae cases
reported between 1934 and 1952 and the present
day (Figure 2). However, the correlation with the
increase in the French population from 39 million in
1920 to almost 60 million in 200322 emphasizes a
decreasing leptospirosis incidence rate (Figure 1).
Indeed, the mean Icterohaemorrhagiae incidence
rate/100 000 inhabitants was 0.36 cases between
1933 and 1952 (excluding the 1939 to 1944
war years), whereas it was 0.23 cases between
1970 and 1986 and 0.20 cases from 1987 to date.
Therefore, there has been a low but continuous
decreasing trend in the incidence rate of Icterohae-
morrhagiae leptospirosis in France during the 20th
century (Figure 1). This decreasing trend is in par-
allel to the urbanization rate (proportion of inhabi-
tants living in settlements of more than 2000
inhabitants).Icterohaemorrhagiae and other serogroups in France from
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Figure 4 Monthly distribution of leptospirosis cases due
to the serogroup Grippotyphosa in France. Comparison of
two distinct time periods.Leptospirosis due to other serogroups
Despite the increasing spectrum of serogroups used
for serological diagnosis from 1942 and overall from
1970, no significant increase either in the number of
leptospirosis cases or in the incidence of the disease
was observed in the seventies (Figures 1 and 2). In
contrast this period was characterized by a rather
low incidence.
In 1985, seven new antigens were added to the
MAT panel. This addition led to an increased number
of identified leptospirosis cases during the late
eighties (Figure 2). From 1985 to date, if leptos-
pirosis cases where the responsible serogroup
could be identified are considered, the relative
importance of each serogroup (Figure 3) was, in
decreasing order, Icterohaemorrhagiae 37.8%,
Grippotyphosa 20.7%, Australis 9.3%, Sejroe 7.1%,
Panama 6.9%, Canicola 6.2% and Cynopteri 3.6%.
The annual fluctuations differed according to the
serogroup. However, in 1987 and 1988 (years char-
acterized by having numerous cases), with 443 and
400 cases respectively, all the main serogroups, with
the exception of Panama, concurred with the rising
incidence (Figure 2). Similarly, in years character-
ized by few cases, for instance 1989 or 1990, the
incidence of most serogroups decreased with the
exception of Panama.
The leptospirosis due predominantly to the Icter-
ohaemorrhagiae serogroup that was observed in
France was also found in other European countries,
Spain,14 Portugal,13 Italy24,25 and Denmark.26 How-
ever in the early 1990s in the Netherlands and the
whole of the United Kingdom, the Hardjo serovar
became the major cause of the disease.10,11,12Figure3 Serogroups involved inhuman leptospirosis from
1985 to 2003 in France. Ict: Icterohaemorrhagiae; Grip:
Grippotyphosa; Aus: Australis; Sej: Sejroe; Pan: Panama;
Can: Canicola; Cyno: Cynopteri; Pom: Pomona; Bat: Bata-
viae; Tar: Tarassovi; Bal: Ballum; Coag: Co-agglutinins.Leptospirosis due to Grippotyphosa
serogroup
The Grippotyphosa serogroup was found to be sec-
ond after Icterohaemorrhagiae in terms of quanti-
tative importance. Although an incidence peak was
also observed from August to November, the
monthly case distribution from 1973 to 2003 was
scattered throughout the whole year (Figure 4). This
distribution contrasted with that previously
observed from 1943 to 1952, with a narrower range
of cases occurring between August and September
(Figure 4 and Erber15). However, this could be due to
a global increase in the number of cases in the
previous years. The seasonal distribution of Grippo-
typhosa leptospirosis was found to be similar to
that of Icterohaemorrhagiae (Figure 5) although
the incidence peak usually occurred later for
Grippotyphosa.Figure 5 Monthly distribution of leptospirosis cases due
to the serogroup Icterohaemorrhagiae. Comparison of two
distinct time periods.
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Figure 6 Monthly distribution of leptospirosis cases due
to the serogroup Pomona. Comparison of two distinct time
periods.Leptospirosis due to Pomona serogroup
Pomona was the third most important serogroup
between 1945 and 1952 and was typically respon-
sible for an occupational disease associated with
pigs. Its monthly distribution was quite distinctive:
present throughout the year with very moderate
recrudescence in the second half (Figure 6 and
Mailloux and Kolochine-Erber27). Nowadays, the
importance of Pomona has decreased and a slight
recrudescence in the second half of the year with a
peak in August is apparent showing that, as for
other serogroups, Pomona leptospirosis has become
associated with holiday periods and contact with
fresh water. However, many cases of Pomona lep-
tospirosis occur throughout the year, suggesting a
significant risk remaining associated with occupa-
tional exposure.
Seasonal variations
With reference to the monthly distribution, a large
increase in the number of Icterohaemorrhagiae lep-
tospirosis cases (Figure 5) was found to occur during
the second half of the year (71.5% of the 3304 cases
recorded between 1973 and 2003). The curve drawn
from data collected from 1973 to 2003 shows an
incidence peak more concentrated over August and
September, than during the 1933—1952 periodwhich
concerns 2555 cases (Figure 5 and Erber15). The
increasing holiday phenomenon in July and August
after the Second World War could be responsible for
this slight change in seasonal distribution. A one-
month delay between contamination and the dis-
ease is usual. The monthly distribution for leptos-
pirosis due to other serogroups is found to be similar
(data not shown) with an incidence peak in Septem-
ber. By contrast, in other European countries large
variations in seasonal distribution have beenreported. Notifications peak mostly in July in
Ireland,10 August in Denmark26 and Italy,24,25
October in England and Wales12 and even December
in Scotland.11
Geographical distribution
The incidence rate of the disease differed according
to the French regions and stability of the traditional
foci was obvious. The mean incidence was calcu-
lated from figures recorded between 1991 and 2003
for which data were available. Four regions had an
incidence rate of leptospirosis >1 case/100 000
inhabitants per year, Franche-Comte´ (1.39) and
Champagne-Ardennes (1.13) in Eastern France,
Aquitaine (1.42) and Poitou-Charentes (1.09) in
South Western France. Two regions in Western
France registered an incidence close to 1 case/
100 000, Pays de Loire (0.88) and Basse-Normandie
(0.97). As expected, dry regions in the south of the
country, such as Languedoc-Roussillon and Prov-
ence-Alpes-Coˆte d’Azur were almost free of leptos-
pirosis: 0.19 and 0.09 cases/100 000 inhabitants,
respectively.
A previous study18 reported the regional distribu-
tion between 1974 and 1983 but the analysis was
restricted to the Icterohaemorrhagiae serogroup
and consequently the incidence rates were lower.
Pays de Loire, Basse-Normandie and Champagne-
Ardennes were less affected than during the 13 most
recent years, with 0.28, 0.24 and 0.10 cases/
100 000 inhabitants, respectively. However the
same regions reported a low incidence, from 0.07
cases in Bretagne, 0.008 in Provence-Alpes-Coˆte
d’Azur and Languedoc-Roussillon. Similarly the
highest incidence was observed in Poitou-Charentes
(0.42), Aquitaine (0.63) and overall in Franche-
Comte´ (0.72). Therefore, the geographical distribu-
tion has remained constant throughout time, lep-
tospirosis foci are probably permanent in relation to
environmental conditions, and relationships
between humans and reservoir hosts are probably
strongly established.
Variation in incidence rates of
leptospirosis
During these 66 years of surveillance, several years
clearly exhibited a higher number of cases than
usual (Figure 1). These outbreaks usually involved
several years (two to five), although a clear peak
was reached in only a given year (1937, 1947, 1983,
1987, 1996). For instance an outbreak occurred from
1936 to 1938. In 1937, 199 cases of Icterohaemor-
rhagiae leptospirosis were observed, i.e., an inci-
dence rate of 0.48/100 000 inhabitants at the
168 G. Baranton, D. Posticnational level for this single serogroup. From 1945 to
1949, high numbers of Icterohaemorrhagiae cases
were registered. This recrudescence could have
been related to a rapid increase in the rat popula-
tion in the period following the war.
Additionally, some of the years of exceptional
leptospirosis incidence can be associated with cli-
matic trends. In 1947, 374 cases were reported,
among them 313 that were due to the serogroup
Icterohaemorrhagiae, leading to a record incidence
rate of 0.77 for icterohaemorrhagic leptospirosis.
The year 1947 was characterized by a heat-wave.
Similarly, 1949 also registered a high incidence,
although the increase was not only due to Ictero-
haemorrhagiae (207 cases) but also to Grippoty-
phosa (146 cases). However, among the 146 cases
due to Grippotyphosa, 75 occurred in a single out-
break.28 Interestingly, 1949 was not only character-
ized by a heat-wave but also by abundant stormy
precipitation in August. Such rainy conditions facili-
tated leptospire migration from soil to surface
waters. This point could be important since during
both 1976 and 2003, which also recorded heat-
waves in July and August but in a context of drought,
either low or normal numbers of cases of leptos-
pirosis (whatever the serogroup) were recorded
with 121 and 318 cases, respectively. In these con-
ditions, rapid desiccation prevented the survival of
leptospires in surface waters. Moreover, the
monthly distribution of leptospirosis cases occurring
in 2003 exhibited a moderate increase during June
and September, whereas the end of the year was
characterized by few cases.20 Despite a greater
opportunity for exposure to contamination through
increased activities in fresh water (drownings
increased by 73% between 2002 and 200329), the
incidence of leptospirosis did not increase. The only
previous comparable heat-wave occurred in
France in 1921, at the beginning of leptospirosis
serodiagnosis. Therefore we lack exploitable data.
However, data on temperature variability registered
in Europe during the last 500 years have recently
been made available.30 We tried to correlate tem-
perature and leptospirosis incidence in France from
1920 by plotting both data on the same graph
(courtesy of J. Luterbacher). No correlation was
obvious, with the exception of a negative correla-
tion between the strong warming trend within the
decade 1994—2003 and decreasing leptospirosis
incidence in France during this same period (data
not shown).
From 1982 to 1984, the number of cases due to
the Icterohaemorrhagiae serogroup was greater
than 200 per year (269 in 1983), although no remark-
able climatic event was observedwith the exception
of floods in 1983 and amarked ‘El Nin˜o’ phenomenonin 1982—1983. However, this phenomenon was prob-
ably unrelated to leptospirosis in France since it
mostly concerned the Pacific Ocean. Moreover,
the 1997—1998 years, which were also character-
ized by a strong ‘El Nin˜o’, showed a normal rate of
incidence of leptospirosis.
Another marked increase of leptospirosis was
noticed in 1987—1988 and 1996 (mainly due to
Grippotyphosa and serogroups other than Icterohae-
morrhagiae). These years did not exhibit any unu-
sual climatic events with the exception of floods in
1987.
Surprisingly, very few correlations could be
established between notifications from the differ-
ent European countries during the last decades of
the 20th century, except in 1988, where France,
England, Wales, Denmark and Italy reported a high
incidence and in 1996 where France, Denmark and
Portugal also reported a high incidence of the dis-
ease. In contrast to France, the incidence was high
in 1983 and 1985 in England andWales,12 in 1992 and
1993 in Ireland,10 in 1971—1974 in Scotland,11 in
1975, 1983 and 1990 in Denmark,26 in 1989 and 1990
in Italy and, finally in 1997 in Portugal.13
With reference to more distant continents, Aus-
tralia and the United States of America also have
surveillance programs. National data from the USA
are available from 1947 onwards. However, human
leptospirosis is infrequently diagnosed and the
number of recorded cases ranges from 142 cases
in 1964 to 40 cases in 1984 for a population about
five times greater than that of France. Therefore,
the incidence is ten to twenty times lower than
that found in France.31 However, no clear trend
can be outlined in states with such low and prob-
ably underestimated incidences of infection. In
Australia, surveillance data only from 1998 to
2002 are available. The number of recorded cases
varies from 322 in 1999 to 170 in 2002, which
corresponds to an incidence more than twice that
of France, ranging from 1.72 cases/100 000 inha-
bitants in 1999 to 0.83 cases/100 000 inhabitants
in 2002.32Conclusion
Data collected since the beginning of leptospirosis
serodiagnosis have not emphasized any cyclic varia-
tion in the incidence of the disease. Even the asso-
ciation with meteorological events is unclear. Only
50% of heat-wave occurrences have led to an
increased number of cases. Precipitation seems to
have played a more important role, at least when
this concerned the whole French territory. It should
be assumed that years characterized by hot sum-
Trends in leptospirosis epidemiology in France 169mers with abundant stormy rain are themost favour-
able for an increase in the incidence of leptospirosis
in areas considered as usual foci. Our observations
probably resulted from the potential association of
several factors: meteorology, agricultural produc-
tion, fluctuations in animal populations and human
behaviour.
We observed that, in contrast with other western
countries where leptospirosis is a notifiable disease,
it is decreasing only slowly in France. The reasons
for such persistence are unclear although the way of
life could account for this in part. For instance,
more than 50% of leptospirosis cases in France are
observed in ‘non-active’ populations: either stu-
dents or retired people. Aquatic recreational activ-
ities for the former and fishing—hunting for the
latter, probably play a prominent role. Otherwise,
France remains a still largely rural country as com-
pared to its neighbours and is deeply involved in
agriculture, breeding and food production, which
lead to favourable environmental conditions for
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